Almonty's Sangdong Mill Hits Full Throughput as Two Brokerages Trim Price Targets

Almonty's restart of the Sangdong tungsten mine is generating two distinct streams of news, and investors would do well to keep them apart. On one side sits a set of operational markers — a mill circuit running at full throughput, recoveries in line with expectations, and a first commercial tungsten shipment. On the other stands a pair of Wall Street brokerages that have cut their price targets while leaving their buy ratings untouched.

The operational update came from CEO Lewis Black roughly two weeks ago. Black reported that the grinding circuit at Sangdong was operating at full throughput and that yields were matching expectations. Those disclosures carry more weight than the shipment headline itself, because they speak to how the plant actually runs rather than to the dispatch of a single lot of product. The same update confirmed that the first container of tungsten concentrate had left the mine for a customer — the first delivery from Sangdong in more than 30 years.

Yet a mill running at full capacity is a positive operating signal, not proof of sustainable delivery performance. Recoveries meeting expectations do not guarantee that every target for the wider expansion will be hit. For shareholders, the transition to commercial shipment and a reliably running operation are separate valuation questions, and the repeatability of such progress matters more than its one-time news value.

Stifel and B. Riley Cut Targets, Keep Buy Ratings

How heavily timing assumptions weigh on the stock became clear on October 20, when Stifel lowered its price target to US$21 from US$25 while maintaining its buy recommendation. According to media reports, the firm pushed back its delivery assumptions in its own model after revising the expected timelines for Sangdong's first and second phases. The move followed Almonty's investor day on October 19, placing the emphasis squarely on project scheduling rather than on operating performance.

Should investors sell immediately? Or is it worth buying Almonty?

B. Riley Securities followed roughly a week ago. Analyst Nick Giles cut his target to US$20 from US$25, also keeping a buy rating. Neither brokerage paired its lower number with a downgrade, which is the key takeaway: the fundamental view survived the revision, but the valuation benchmark came down. What the B. Riley cut cannot be presented as is a proven cause of any particular day's share price move.

Reading too much into either signal would be a mistake. Focusing only on the buy ratings overlooks the reduced valuations; inferring a blanket rejection of the company from lower targets is equally short-sighted. A positive milestone and more cautious valuation assumptions can coexist without contradiction.

Korean Listing Talk Sits Outside the Operating Debate

Media reports indicate that on October 26 Almonty discussed a possible Korean listing, including via Korean Depositary Receipts, while keeping its Nasdaq listing in place. That is a supplementary capital-markets topic, not a substitute for operational proof.

Almonty at a turning point? This analysis reveals what investors need to know now.

Taken together, the reported performance of the grinding circuit argues against a broadly pessimistic reading, while the adjustments to delivery models argue against euphoria. Almonty has reported progress; what would strengthen the investment case is a consistently reliable operation. That yardstick holds up better than listing plans or the unchanged positive label of a buy recommendation.

Ad

Almonty Stock: New Analysis - 5 November

Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Almonty analysis...